GO:0015074 DNA integration: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015074 DNA integration is the biological process in which a DNA segment is incorporated into another, usually larger, DNA molecule such as a chromosome.
• DNA integration is central to the life cycles of retroviruses, hepatitis B virus (HBV), and bacterial/plant transformation systems such as Agrobacterium.
• HBV DNA integration into host chromosomes is a major driver of hepatocellular carcinoma (HCC) and provides a biomarker for HBV-related HCC.
• Integration is not random: specialized DNA structures and chromatin context influence where and how efficiently integration occurs.
• Mitochondrial DNA can also be a target of HBV integration, expanding the subcellular landscape of integration events.
• CRISPR/Cas-based tools now enable programmable large DNA fragment integration for research and therapeutic applications.
Description
DNA integration (GO:0015074) is the process by which a DNA segment is incorporated into another, usually larger, DNA molecule such as a chromosome. This process is fundamental to the replication cycles of many mobile genetic elements, including retroviruses and hepatitis B virus (HBV), and it underlies natural horizontal gene transfer systems such as Agrobacterium-mediated plant transformation. Because integration permanently alters the host genome, it has profound consequences for genome stability, gene expression, and disease development. Researchers study DNA integration to understand viral pathogenesis, cancer initiation, and to develop tools for precise genome engineering. The process is influenced by specialized DNA structures that act as genomic beacons, by chromatin context, and by the geometric properties of DNA loops that can catalyze integration. In the clinic, HBV DNA integration is recognized as a key driver of carcinogenesis and a promising biomarker for HBV-related hepatocellular carcinoma (HCC). Mitochondrial DNA has also been identified as a target of HBV integration, highlighting the broad subcellular reach of this process. Recent advances in CRISPR/Cas-based gene editing now allow researchers to harness large DNA fragment integration for therapeutic and synthetic biology applications.
DNA integration At A Glance
| GO ID | GO:0015074 |
|---|---|
| GO term | DNA integration |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Incorporation of a DNA segment into another, usually larger, DNA molecule such as a chromosome |
| Biological context | Viral life cycles, mobile genetic elements, horizontal gene transfer, genome engineering |
| Disease relevance | Hepatocellular carcinoma, viral pathogenesis, genomic instability |
| Key experimental models | HBV infection models, retroviral vectors, Agrobacterium-mediated transformation, CRISPR/Cas knock-in |
What Is GO:0015074?
According to the Gene Ontology, DNA integration (GO:0015074) is defined as the process in which a DNA segment is incorporated into another, usually larger, DNA molecule such as a chromosome. This definition captures both the molecular event of strand joining and the biological context in which a foreign or mobile DNA element becomes a stable part of a host genome. The term is classified under the biological_process aspect of the ontology. It encompasses integration events mediated by viral integrases, transposases, and other recombinases, as well as experimental integration achieved through genome engineering tools.
Why Is DNA integration Important in Cell Biology?
DNA integration is important because it permanently modifies the genetic material of a cell, with far-reaching consequences for viral persistence, cancer development, and genome engineering. In chronic HBV infection, integration of viral DNA into host chromosomes drives carcinogenesis and provides a new biomarker for HBV-related HCC. Understanding the structural and chromatin determinants of integration is essential for predicting insertion sites and for designing safer gene therapy vectors. Moreover, the ability to program large DNA fragment integration using CRISPR/Cas tools is transforming both basic research and therapeutic development.
• HBV DNA integration is a major driver of hepatocellular carcinoma and a candidate biomarker for HBV-related HCC.
• Integration events can cause insertional mutagenesis, altering oncogene or tumor suppressor expression.
• Specialized DNA structures act as genomic beacons that guide integration by evolutionarily diverse retroviruses.
• Chromatin context influences the efficiency of Agrobacterium T-DNA integration and transgene expression.
• DNA loops can act as geometric catalysts that promote integration.
• Mitochondrial DNA is a target of HBV integration, expanding the subcellular scope of integration research.
• CRISPR/Cas-based tools enable programmable large DNA fragment integration for research and therapy.
• Studying integration mechanisms informs antiviral R&D and the development of integration inhibitors.
• Integration site analysis is critical for assessing the safety of gene therapy vectors.
• Model systems ranging from HBV infection to plant transformation provide complementary insights into integration.
What Happens During DNA integration?
Recognition of target DNA and formation of specialized structures
In simple terms: The incoming DNA first finds and recognizes a suitable spot in the host genome.
Integration begins with the recognition of target DNA sequences or structures. Specialized DNA structures, such as bent or distorted DNA, can act as genomic beacons that guide integration by evolutionarily diverse retroviruses. In the case of HBV, integration targets are influenced by the accessibility of the host genome and the presence of specific DNA motifs. Chromatin context also plays a role, as Agrobacterium T-DNA integration is affected by the chromatin state of the target region.
Cleavage of the target DNA and the incoming segment
In simple terms: Enzymes cut both the host DNA and the incoming DNA to prepare them for joining.
After target recognition, the integration machinery cleaves the host DNA at the insertion site and processes the ends of the incoming DNA segment. For retroviruses, the integrase enzyme performs 3-prime processing of the viral DNA ends and strand transfer into the host chromosome. In HBV, integration is thought to involve host DNA repair enzymes and viral proteins, although the precise mechanism remains an area of active investigation. The geometry of DNA loops can catalyze these cleavage and joining reactions by bringing reactive ends into proximity.
Strand transfer and joining of DNA ends
In simple terms: The cut DNA pieces are joined together, stitching the new segment into the host genome.
Strand transfer covalently links the incoming DNA to the host chromosome. This step is catalyzed by integrases or recombinases and can be influenced by the local DNA topology. In Agrobacterium-mediated transformation, the T-DNA strand is transferred into the plant cell nucleus and integrated into the plant genome, a process modulated by chromatin. For HBV, integration occurs via a non-replicative mechanism that often involves host DNA repair pathways.
Repair and resolution of the integration intermediate
In simple terms: The cell repairs the remaining gaps and seals the DNA, making the insertion permanent.
Following strand transfer, host DNA repair machinery resolves the integration intermediate by removing flaps, filling gaps, and ligating the DNA. This repair step can introduce small deletions or duplications at the integration site. In HBV-related HCC, integrated viral DNA often contains rearrangements and deletions that contribute to genomic instability. The efficiency of repair influences the overall frequency of stable integration events.
Chromatin remodeling and transcriptional consequences
In simple terms: The cell adjusts the local chromatin, which can turn nearby genes on or off.
Once integrated, the new DNA segment becomes subject to chromatin regulation. Chromatin structure affects both the integration process and the subsequent expression of the integrated transgene. In HBV integration, viral enhancers and promoters can drive expression of host oncogenes or produce chimeric transcripts that promote carcinogenesis. Mitochondrial DNA integration of HBV may also alter mitochondrial gene expression and function.
Clonal expansion of cells carrying integrated DNA
In simple terms: Cells with the new DNA can survive and multiply, leading to a population of altered cells.
If the integration event provides a selective advantage, the affected cell can clonally expand. In chronic HBV infection, hepatocytes with integrated viral DNA can undergo clonal expansion, contributing to tumor development. This clonal expansion is a hallmark of HBV-related HCC and can be detected by integration site analysis.
Key Genes Involved in GO:0015074 DNA integration
The following genes and proteins are central to the study of DNA integration, based on published literature on viral integration, genome engineering, and host factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HBV X protein (HBx) | Viral regulatory protein that modulates host gene expression and contributes to carcinogenesis | Key factor in HBV integration-driven HCC |
| HBV surface antigen (HBsAg) | Viral envelope protein; its integration-derived expression is a biomarker | Used for HCC detection and monitoring |
| Integrase (retroviral) | Catalyzes 3-prime processing and strand transfer of viral DNA | Target for antiviral drugs and vector design |
| Agrobacterium VirD2 | Bacterial protein that pilots T-DNA into plant cells | Model for horizontal gene transfer |
| Agrobacterium VirE2 | Single-stranded DNA-binding protein that protects T-DNA | Studied for plant transformation efficiency |
| Cas9 | RNA-guided nuclease that creates double-strand breaks for integration | Enables CRISPR/Cas knock-in |
| Cas12a | Alternative RNA-guided nuclease with staggered cuts | Used for large DNA fragment integration |
| Host DNA repair genes (e.g., ATM, BRCA1) | Repair integration intermediates and maintain genome stability | Determine integration efficiency and fidelity |
| DNA ligase IV | Joins DNA ends during non-homologous end joining | Influences integration outcomes |
| Histone proteins | Package DNA and regulate chromatin accessibility | Modulate integration site selection |
| Mitochondrial DNA (mtDNA) | Target of HBV integration | Expands integration research to mitochondria |
| Retroviral integrase (IN) | Essential for proviral integration | Target for integrase strand transfer inhibitors |
| HBV core protein | Forms viral capsid and interacts with host DNA | May influence integration targeting |
| DNA topoisomerase | Relieves DNA supercoiling during integration | Potential cofactor in integration |
| Ku70/Ku80 | Heterodimer involved in non-homologous end joining | Affects integration repair |
| RAD51 | Homologous recombination repair protein | May compete with integration pathways |
| TP53 | Tumor suppressor that responds to DNA damage | Mutated in many HBV-related HCCs |
How Is DNA integration Regulated?
DNA integration is regulated at multiple levels. Chromatin structure and histone modifications influence the accessibility of target DNA and the efficiency of integration. Specialized DNA structures, such as bent or looped DNA, can act as geometric catalysts that promote integration. Host DNA repair pathways, including non-homologous end joining and homologous recombination, determine the fate of integration intermediates and the fidelity of the final product. In the context of HBV, viral proteins and host factors modulate integration frequency and site selection. Additionally, antiviral R&D efforts are exploring inhibitors that target integration-associated enzymes.
DNA integration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HBV | Hepatocellular carcinoma | HBV infection of primary human hepatocytes or HepG2-NTCP cells |
| Retroviral integrase | Viral persistence and insertional mutagenesis | Retroviral vector transduction of cell lines |
| Agrobacterium VirD2/VirE2 | Crown gall disease and plant transformation | Agrobacterium-mediated transformation of Arabidopsis or tobacco |
| mtDNA | HBV integration into mitochondria | Mitochondrial isolation and sequencing from HBV-infected cells |
| Cas9/Cas12a | Genome engineering and therapeutic integration | CRISPR/Cas knock-in in human cell lines |
HBV integration and hepatocellular carcinoma
Chronic hepatitis B virus infection is a major risk factor for hepatocellular carcinoma (HCC). HBV DNA integration into the host genome drives carcinogenesis by causing insertional mutagenesis, inducing chromosomal instability, and producing chimeric viral-host transcripts that promote cell proliferation. Integrated HBV DNA also provides a new biomarker for HBV-related HCC, as integration sites can be detected in circulating tumor DNA. Clonal expansion of hepatocytes carrying integrated HBV DNA is a hallmark of chronically infected livers and contributes to tumor heterogeneity.
Mitochondrial DNA as a target of HBV integration
Beyond the nuclear genome, mitochondrial DNA (mtDNA) has been identified as a target of HBV integration. This finding expands the subcellular landscape of HBV integration and suggests that mtDNA integration may affect mitochondrial function and cellular metabolism. The consequences of mtDNA integration for disease progression and antiviral responses are an active area of research.
Retroviral integration and insertional mutagenesis
Retroviruses integrate their proviral DNA into the host genome as an essential step in their replication cycle. While this is required for viral persistence, it can also cause insertional mutagenesis, activating oncogenes or disrupting tumor suppressor genes. Understanding how specialized DNA structures act as genomic beacons for integration by evolutionarily diverse retroviruses can inform the design of safer retroviral vectors for gene therapy.
Agrobacterium-mediated transformation and plant disease
Agrobacterium tumefaciens causes crown gall disease by transferring and integrating T-DNA into the plant genome. Chromatin context influences T-DNA integration and transgene expression, which has implications for plant biotechnology and for understanding natural horizontal gene transfer.
From DNA integration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote HBV integration? | Knockout of gene X in HBV-infected hepatocytes followed by integration site sequencing |
| Does a point mutation in integrase affect integration efficiency? | Point-mutation knock-in of integrase variants in retroviral vectors |
| Can a reporter gene be integrated at a specific locus? | Knock-in of fluorescent reporter using CRISPR/Cas9 |
| Does chromatin state affect T-DNA integration? | Tagged knock-in of histone variants in plant cells |
| Does overexpression of HBx increase integration? | Overexpression of HBx in hepatocyte cell lines |
| Does mtDNA integration alter mitochondrial function? | Knockout of mtDNA integration sites using mito-TALENs or CRISPR |
How to Study the DNA integration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Integration site sequencing | Genomic locations of integrated DNA | HBV integration in HCC, vector safety |
| ChIP-seq | Chromatin state at integration sites | Studying chromatin influence on integration |
| CRISPR/Cas9 knock-in | Targeted integration of donor DNA | Gene tagging, therapeutic integration |
| Digital PCR | Quantification of integrated viral DNA | Biomarker for HBV-related HCC |
| Mitochondrial DNA sequencing | HBV integration into mtDNA | Subcellular integration studies |
| In vitro integration assays | Enzymatic activity of integrases | Antiviral drug screening |
| DNA topology assays | Geometric effects on integration | Studying DNA loops as catalysts |
| Agrobacterium transformation | T-DNA integration efficiency | Plant biotechnology |
Integration site sequencing
Integration site sequencing (e.g., inverse PCR, ligation-mediated PCR, or next-generation sequencing) identifies the genomic locations where foreign DNA has integrated. This method is widely used to study HBV integration in HCC and to assess the safety of gene therapy vectors.
Chromatin immunoprecipitation (ChIP)
ChIP can be used to examine the chromatin context at integration sites, revealing how histone modifications and chromatin accessibility influence integration efficiency.
CRISPR/Cas-based knock-in
CRISPR/Cas systems enable programmable integration of large DNA fragments by creating targeted double-strand breaks and providing a donor template. This approach is used to study gene function and to develop therapeutic integration strategies.
Mitochondrial DNA analysis
PCR and sequencing of mitochondrial DNA can detect HBV integration events in mitochondria, providing insights into the subcellular distribution of integration.
How CRISPR Can Be Used to Study GO:0015074 DNA integration
Knockout
CRISPR/Cas9 knockout can be used to disrupt host genes suspected to be involved in DNA integration, such as DNA repair factors or viral receptors. For example, knocking out genes required for HBV entry or repair can reduce integration frequency and help identify therapeutic targets.
Point Mutation
Point mutations can be introduced into integrase or host factors to dissect the catalytic residues and regulatory sites required for integration. This approach helps determine which amino acids are essential for strand transfer and repair.
Knock-in
Knock-in of reporter genes or tags at specific genomic loci using CRISPR/Cas9 allows researchers to track integration events and study the consequences of integration on gene expression. Large DNA fragment integration is now feasible with advanced CRISPR/Cas tools.
Overexpression
Overexpression of viral or host proteins, such as HBx or integrase, can increase integration frequency and help study the mechanisms and consequences of integration in cell models.
How EDITGENE Supports DNA integration Research
Researchers studying DNA integration-related genes often need to determine whether a candidate gene is causally involved in the integration process or is merely a bystander. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic modifications, from knockout to knock-in, in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for DNA integration research.
Frequently Asked Questions About DNA integration
What is DNA integration (GO:0015074)?
DNA integration is the biological process in which a DNA segment is incorporated into another, usually larger, DNA molecule such as a chromosome.
What genes are involved in DNA integration?
Key genes include HBV X protein, retroviral integrase, Agrobacterium VirD2/VirE2, Cas9, Cas12a, and host DNA repair genes such as ATM and BRCA1.
How does HBV DNA integration cause liver cancer?
HBV integration can cause insertional mutagenesis, chromosomal instability, and expression of chimeric viral-host transcripts that promote hepatocyte proliferation and carcinogenesis.
Is DNA integration random?
No, integration is influenced by specialized DNA structures, chromatin context, and DNA topology, which can guide integration to preferred sites.
Can mitochondrial DNA be a target of integration?
Yes, mitochondrial DNA has been identified as a target of HBV integration.
What methods are used to study DNA integration?
Common methods include integration site sequencing, ChIP-seq, CRISPR/Cas knock-in, digital PCR, and mitochondrial DNA sequencing.
How can CRISPR be used to study DNA integration?
CRISPR can create knockouts, point mutations, knock-ins, and overexpression models to dissect the role of specific genes in integration.
What is the role of chromatin in DNA integration?
Chromatin structure affects the accessibility of target DNA and the efficiency of integration, as shown for Agrobacterium T-DNA integration.
Are there antiviral drugs targeting integration?
Antiviral R&D is exploring inhibitors of integration-associated enzymes, such as integrase strand transfer inhibitors for retroviruses.
How does DNA integration relate to gene therapy?
Programmable integration using CRISPR/Cas tools enables precise insertion of therapeutic genes, but safety concerns about off-target integration remain.
Conclusion
DNA integration (GO:0015074) is a fundamental biological process with broad implications for viral pathogenesis, cancer, and genome engineering. HBV integration drives hepatocellular carcinoma and serves as a biomarker, while retroviral and Agrobacterium integration systems provide mechanistic insights. Advances in CRISPR/Cas-based integration are opening new avenues for research and therapy. Understanding the molecular and chromatin determinants of integration will continue to inform antiviral strategies and safe genome editing.
References
- 1. Yeh SH et al.. 2023. Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC.. Cell Mol Gastroenterol Hepatol 15(4):921-929 PMID: 36690297
- 2. Kohio HP et al.. 2023. Specialized DNA Structures Act as Genomic Beacons for Integration by Evolutionarily Diverse Retroviruses.. Viruses 15(2) PMID: 36851678
- 3. Mason WS et al.. 2021. Hepatitis B Virus DNA Integration and Clonal Expansion of Hepatocytes in the Chronically Infected Liver.. Viruses 13(2) PMID: 33573130
- 4. Giosa D et al.. 2023. Mitochondrial DNA is a target of HBV integration.. Commun Biol 6(1):684 PMID: 37400627
- 5. Phondeth L et al.. 2025. Biology of hepatitis B virus DNA integration and its impact on antiviral R&D.. Antiviral Res 244:106305 PMID: 41197811
- 6. Battaglia C et al.. 2024. Loops are geometric catalysts for DNA integration.. Nucleic Acids Res 52(14):8184-8192 PMID: 38864388
- 7. Gelvin SB et al.. 2007. Effect of chromatin upon Agrobacterium T-DNA integration and transgene expression.. Biochim Biophys Acta 1769(5-6):410-21 PMID: 17544520
- 8. Yang S et al.. 2025. CRISPR/Cas-Based Gene Editing Tools for Large DNA Fragment Integration.. ACS Synth Biol 14(1):57-71 PMID: 39680738
